Arrowhead Pharmaceuticals Aktie
14,75
EUR
+0,82
EUR
+5,89
%
16,06
USD
-0,78
USD
-4,63
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
07.09.18 | Arrowhead Pharmaceuticals Buy | B. Riley FBR | |
06.09.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
08.08.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
02.07.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
09.05.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
10.11.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
19.05.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets |
Werbung
Werbung